Epicutaneous Immunotherapy for Treatment of Peanut Allergy: Follow-up from the Consortium for Food Allergy Research

pa.ythelady61 shared this article with you from Inoreader Epicutaneous Immunotherapy for Treatment of Peanut Allergy: Follow-up from the Consortium for Food Allergy Research Via Journal of Allergy and Clinical Immunology Capsule Summary: With extended Viaskin peanut 250 mcg treatment for 130 weeks, persistent desensitization and immunomodulatory changes were observed, associated with favorable safety, tolerability, and adherence profiles. Treatment success was observed predominantly in younger participants. View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.